The Discoverer of Immunocal ~ Dr. Gustavo Bounous

Educated at the University of Turin and the University of Genoa in his native Italy, Gustavo Bounous’ distinguished career in medical research began as a Research Fellow in surgery at the Indiana Medical Center, Indianapolis. In 1963, he moved to Canada and commenced an academic career that led him to become Professor of Surgery, firstly at the University of Sherbrooke (1973-1985), then at McGill University (1985-1993).

Dr. Bounous was awarded the 1965 medal of the Royal College of Physicians and Surgeons of Canada. He pioneered the use of elemental diets in the prophylaxis and treatment of intestinal lesions associated with shock, intestinal ischemia, radiation, cancer chemotherapy and Crohn’s disease.

In 1968, he was named Career Investigator of the Medical Research Council, an award that was reconfirmed until 1993, the year of his retirement from McGill University. In 1978, Dr. Bounous initiated a novel research program to search for a dietary protein source that would boost the immune system, in conjunction with a colleague from the McGill University Faculty of Medicine. Studies led to the discovery of an undenatured serum milk concentrate that sustains normal glutathione levels and promotes immune enhancing activity. Subsequent identification of the active ingredients present in this protein mixture, brought on in 1993, the production of a high-quality bioactive material given the name and trademark Immunocal®.

Now... "In this inaugural year of the Fund, Immunotec’s Scientific Advisory Board has chosen to advance the scientific programs of the McGill Department of Oncology and the Centre for Translational Research in Cancer by funding the work of Dr. Thomas Jagoe. Dr. Jagoe’s research project is entitled: “Mitochondrial-targeted fluorescent signals in real-time imaging to monitor morphological adaptation and aid functional correlation in muscle tissue.”

The Dr. Gustavo Bounous Fund provides financial resources to carry forward the legacy of Dr. Gustavo Bounous, who has dedicated his life to identifying, through research, ways to improve the health and wellness of people around the world.

On behalf of Immunotec, its Distributors across North America and its international Licensees, Immunotec will award $50,000 for these key investigations into cancer cachexia, for the betterment of health and wellness worldwide.

If you are commited to improved health and ongoing research into a disease that affects so many of our families, we invite you to partner with us by making a donation to the Dr. Gustavo Bounous Fund. Cheques should be made payable to “McGill University – Dr. Gustavo Bounous Fund” and sent to our offices at 300 Joseph-Carrier, Vaudreuil-Dorion, J7V 5V5 for forwarding to McGill. Be assured that the funds will go directly to McGill and tax receipts will be issued by them."

"Sincerely,



James A. Northrop
President & CEO "

Source:
http://www.immunotecglobal.com/en/immunotecglobal/news.aspx?id=235

I can never explain how this discovery has changed my life or all the lives we have touched.
Thank You Dr.Bounous, so much for your hard work and perceverence over those 20 years.
The world is much better place because of you.

Your Devoted Colleague,
Randy Grover

These sites will help answer some questions you may have about the discovery of Immunocal.

http://www.immunotecglobal.com/
and
http://www.immunocal.com/

The Discoverer of Immunocal ~ Dr. Gustavo Bounous